- Home
- YYAI vs ATHA Comparison
YYAI vs ATHA Comparison
Compare YYAI & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYAI
- ATHA
- Stock Information
- Founded
- YYAI 2015
- ATHA 2011
- Country
- YYAI United States
- ATHA United States
- Employees
- YYAI N/A
- ATHA N/A
- Industry
- YYAI
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- YYAI
- ATHA Health Care
- Exchange
- YYAI NYSE
- ATHA Nasdaq
- Market Cap
- YYAI 19.5M
- ATHA 22.3M
- IPO Year
- YYAI N/A
- ATHA 2020
- Fundamental
- Price
- YYAI $1.03
- ATHA $0.54
- Analyst Decision
- YYAI
- ATHA Buy
- Analyst Count
- YYAI 0
- ATHA 4
- Target Price
- YYAI N/A
- ATHA $11.25
- AVG Volume (30 Days)
- YYAI 539.5K
- ATHA 325.4K
- Earning Date
- YYAI 12-24-2024
- ATHA 11-07-2024
- Dividend Yield
- YYAI N/A
- ATHA N/A
- EPS Growth
- YYAI N/A
- ATHA N/A
- EPS
- YYAI N/A
- ATHA N/A
- Revenue
- YYAI N/A
- ATHA N/A
- Revenue This Year
- YYAI N/A
- ATHA N/A
- Revenue Next Year
- YYAI N/A
- ATHA N/A
- P/E Ratio
- YYAI N/A
- ATHA N/A
- Revenue Growth
- YYAI N/A
- ATHA N/A
- 52 Week Low
- YYAI $0.95
- ATHA $0.41
- 52 Week High
- YYAI $53.00
- ATHA $4.30
- Technical
- Relative Strength Index (RSI)
- YYAI 22.69
- ATHA 36.91
- Support Level
- YYAI $0.97
- ATHA $0.56
- Resistance Level
- YYAI $1.47
- ATHA $0.61
- Average True Range (ATR)
- YYAI 0.17
- ATHA 0.04
- MACD
- YYAI 0.06
- ATHA -0.01
- Stochastic Oscillator
- YYAI 14.26
- ATHA 8.45
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.